|
LOC723972 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.818000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.624220E-01 |
| Normal-vs-Stage2 |
7.112000E-01 |
| Normal-vs-Stage3 |
3.156200E-02 |
| Normal-vs-Stage4 |
5.028100E-02 |
| Stage1-vs-Stage2 |
6.307000E-01 |
| Stage1-vs-Stage3 |
3.090600E-01 |
| Stage1-vs-Stage4 |
4.147000E-01 |
| Stage2-vs-Stage3 |
3.333600E-01 |
| Stage2-vs-Stage4 |
3.677400E-01 |
| Stage3-vs-Stage4 |
9.492600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.517700E-02 |
| Normal-vs-AfricanAmerican |
4.620800E-01 |
| Normal-vs-Asian |
6.083400E-01 |
| Caucasian-vs-AfricanAmerican |
5.832000E-01 |
| Caucasian-vs-Asian |
8.773000E-01 |
| AfricanAmerican-vs-Asian |
9.552200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.728300E-02 |
| Normal-vs-Female |
2.934200E-01 |
| Male-vs-Female |
2.059400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.182400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.103360E-01 |
| Normal-vs-Age(61-80Yrs) |
6.456300E-02 |
| Normal-vs-Age(81-100Yrs) |
6.688100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.886400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.525000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.430200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.100000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.586000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.057800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.372400E-01 |
| Normal-vs-Grade 2 |
1.290610E-01 |
| Normal-vs-Grade 3 |
3.100000E-02 |
| Normal-vs-Grade 4 |
4.441600E-01 |
| Grade 1-vs-Grade 2 |
4.432400E-02 |
| Grade 1-vs-Grade 3 |
1.266300E-02 |
| Grade 1-vs-Grade 4 |
2.864400E-01 |
| Grade 2-vs-Grade 3 |
4.295000E-01 |
| Grade 2-vs-Grade 4 |
5.997600E-01 |
| Grade 3-vs-Grade 4 |
3.130600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.158800E-01 |
| Normal-vs-ccB subtype |
4.845000E-04 |
| ccA subtype-vs-ccB subtype |
2.429900E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.219800E-02 |
| Normal-vs-N1 |
5.374400E-01 |
| N0-vs-N1 |
8.921800E-01 |
|
|
